MB2 HEALTH LTD - Accounts

MB2 HEALTH LTD
Statement of Financial Position
As at 31 January 2026

	2026
	£	£
Fixed assets		1,491
Current assets	7,454
Creditors: amount falling due within one year	(8,846)
Net current assets		(1,392)
Total assets less current liabilities		99
Net assets		99


Capital and reserves		99

NOTES TO THE ACCOUNTS

General Information

MB2 HEALTH LTD is a private company, limited by shares, registered in England and Wales, registration number 16194509, registration address 2 Kidbrooke Way, London, England, SE3 0JB.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.

Dividends

Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Computer Equipment

3 Straight Line

Provisions

Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.

Tangible fixed assets

Cost or valuation	Computer Equipment	Total
	£	£
At 20 January 2025	-	-
Additions	1,968	1,968
Disposals	-	-
At 31 January 2026	1,968	1,968
Depreciation
At 20 January 2025	-	-
Charge for period	477	477
On disposals	-	-
At 31 January 2026	477	477
Net book values
Closing balance as at 31 January 2026	1,491	1,491
Opening balance as at 20 January 2025	-	-

3.	Average number of employees Average number of employees during the period was 2.

Advances and Credits

Loans to participators
Loans to participators At the end of the financial year the amount of £4797.00 was owed to the company by the company's Director. This was fully repaid back to the company on 19 June 2026.

Current year (2026)

	Brought Forward £		Amount £		Interest £		Repaid £		Written Off £		Waived £		Carry Forward £
Loans to participators	0		4,797		0		0		0		0		4,797
	0		4,797		0		0		0		0		4,797

For the period ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the director on 24 July 2026 and were signed by:

--------------------------------
Filipe Alves Da Silva Pereira Da Costa
Director

Registered Number: 16194509
England and Wales
MB2 HEALTH LTD

Unaudited Financial Statements

Period of accounts Start date: 20 January 2025 End date: 31 January 2026